1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,500 | 5,750 | 20:46 |
► 26.05.: | | | | | | | | |
► 25.05.: | | | | | | | | |
► Aktueller 4BASEBIO Börsenkurs + Xetra-Orderbuch
► 25.05.: | | | | | | | | |
► Aktueller 4BASEBIO Börsenkurs + Xetra-Orderbuch
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 35,000 | 6 | |||
| 22,200 | 30 | |||
| 16,000 | 500 | |||
| 15,000 | 15 | |||
| 5,750 | 1.965 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/88q.htm [/URL] | ||||
| 1.965 | 5,500 | |||
| 191 | 5,100 | |||
| 1.061 | 0,001 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 3.217 | 0,782 | 2.516 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:35:52 | 5,250 | 34 |
| Tagesumsatz Xetra | -0,150 -2,78 % | 34 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | 4basebio Plc - Director Dealing | 299 | PR Newswire | 4basebio Plc - Director Dealing
PR Newswire
LONDON, United Kingdom, May 22
4basebio PLC("4basebio" or the "Company")
... ► Artikel lesen | |
| 4BASEBIO Aktie jetzt für 0€ handeln | |||||
| Mi | EARNINGS AND TRADING: 4basebio revenue surges in "step-change" year | 9 | Alliance News | ||
| Mi | 4basebio signs clinical supply deal for Phase II trial | 9 | Investing.com | ||
| Mi | 4basebio reports 81% revenue growth, narrows losses for 2025 | 8 | Investing.com | ||
| Mi | 4basebio steigert Umsatz um 81 % - Investitionen führen zu höherem Verlust | 12 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
45 Nachrichten in den letzten 12 Monaten
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 13:06 | Cartesian Therapeutics, Inc.: Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027 | GlobeNewswire (Europe) | Secured up to $150 million of non-dilutive financing from K2 HealthVentures; funding of $50 million from initial tranche extends cash runway into 2028 Financing strengthens Cartesian's financial flexibility... ► Artikel lesen | |
| 17:06 | Alaunos Therapeutics, Inc.: Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies | GlobeNewswire (Europe) | ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, including reductions in body weight and fat mass, improved insulin sensitivity, enhanced adipose function... ► Artikel lesen | |
| 19:06 | MaaT Pharma Provides Business Update and Reports Financial Results for the First Quarter 2026 | Business Wire |
MaaT013 (Xervyteg):
In May 2026, the Company was informed of a "negative trend" opinion on its Marketing Authorization Application from the Committee for Medicinal Products for Human Use... ► Artikel lesen | |
| 13:38 | Glow Lifetech Corp.: Glow Lifetech Reports Record Q1 2026 Results; 35% YoY Revenue Growth, 27% Sequential Growth and Continued National Expansion Momentum | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 26, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the first quarter... ► Artikel lesen | |
| 16:54 | Swedish Orphan Biovitrum AB: New analysis shows Tryngolza (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia | PR Newswire | STOCKHOLM, May 26, 2026 /PRNewswire/ -- Sobi (STO: SOBI) today announced results from a new analysis of the pivotal Phase 3 CORE and CORE2 trials, showing Tryngolza (olezarsen) reduced the... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu 4BASEBIO PLC finden Sie auf Wallstreet Online.